';
Substance Use Disorder

Today, the Department of Drug and Alcohol Programs (DDAP) was joined by national nonprofit Shatterproof and substance use disorder treatment provider Gaudenzia to announce the expansion of the free and confidential Addiction Treatment Locator, Assessment, and Standards Platform (ATLAS) to Pennsylvania.

ATLAS evaluates addiction treatment facilities’ use of evidence-based best practices based on the Shatterproof National Principles of Care, includes an assessment to understand the appropriate level of care, and offers an easy-to-use dashboard to allow those in need and their loved ones to search for and compare facilities using criteria such as location, services offered, and insurance accepted so they can find the best treatment for their unique needs. ATLAS is fully available in English and Spanish.

“We are grateful for ATLAS and the team at Shatterproof for making the submission process so easy,” said Dr. Dale Klatzker, President and CEO at Gaudenzia, Inc. “It is vital that we reduce barriers to treatment, and this tool provides an easy way for those in need to seek and quickly find a treatment option that will work best for them.”

Forty Gaudenzia treatment locations and a total of 515 substance use disorder treatment facilities across the state have submitted their information to be included in ATLAS. An additional open enrollment period for facilities who missed the first deadline will be available in fall 2022.

assistance, support, guidance - business concept words in color hexagons over blue background, flat design

The Department of Human Services (DHS) is pleased to announce new provider enrollment portal enhancements designed to improve a provider’s enrollment experience. Providers will enter the enrollment portal from PROMISe™ using their existing registered login criteria. Upon successful login, providers will have access to these new enhancements:

  1. Applications for adding additional service locations, revalidations, and reactivations will prepopulate parts of your application;
  2. After logging into the portal, existing providers will be able to submit change requests to update their provider file without the need to complete a full application; and
  3. Proof of provider enrollment status with PA Medicaid is available to view and print.

See the PROMISe Quick Tips update for more information. If you do not have an existing login, please select “Register Now” in the Provider Login box and complete the process options. Additional enhancements are planned and will be communicated through future banner alerts and quick tips.

If you have further questions, please contact RCPA Policy Director Jim Sharp.

The Pennsylvania Department of State (DOS) has reversed course and extended its waiver allowing for an initial prescription of buprenorphine without an in-person physical exam. DOS had announced previously that the waiver would expire on June 30, 2022; however, DOS’s waiver will now continue until the last day of the federal public health emergency declaration, unless the exemptions are ended sooner by the Substance Abuse and Mental Health Services Administration (SAMHSA) or the US Drug Enforcement Administration (DEA).

On Sept. 4, 2020, DOS issued a waiver suspending the State Board of Medicine’s regulation at 49 Pa. Code § 16.92(b)(1), which requires an initial physical examination of a patient prior to prescribing buprenorphine for the treatment of opioid use disorder. This waiver was sought specifically to complement the Department of Drug and Alcohol Programs’ (DDAP) suspension of 28 Pa. Code § 715.9(a)(4) and “relates to Federal exemptions granted under the Federal public health emergency (PHE) declaration,” specifically the exemptions granted by the federal Substance Abuse and Mental Health Services Administration (SAMHSA) and the U.S. Drug Enforcement Agency (DEA).

Therefore, in accordance with section 2102-F(a.3) of the Pennsylvania Administrative Code of 1929 (amended by Act 14 of 2022), the Department of State’s waiver will continue until the last day of the federal public health emergency declaration, unless the exemptions are ended sooner by SAMHSA or the DEA. This waiver will not expire on June 30, 2022. More information about the federal public health emergency can be found here.

It is important to note that, to be considered within the acceptable and prevailing standard of care, the physician/prescriber must be following the applicable SAMHSA/DEA guidelines.

Pennsylvania has not received notification that the PHE will be terminated on July 15. The commonwealth expects the PHE to be extended again. If this occurs, this waiver and others tied to or related to the PHE will be extended until mid-October 2022.

Additional information:

Tuesday, July 12, 2022 • 4:00 pm – 5:00 pm

The PA Department of Health (DOH), Department of Human Services (DHS) and Management Agency, and the Jewish Healthcare Foundation are jointly hosting an informational webinar on COVID-19 Therapeutics.

Outpatient COVID-19 treatment and preventive therapies can improve patient outcomes and save lives. Oral antivirals (Paxlovid, Lagevrio) and monoclonal antibodies for pre-exposure prophylaxis (Evusheld) are now widely available in Pennsylvania, but more can be done to improve awareness, access, and equity. This session is intended for providers and facility administrators and will cover why, when, and how to prescribe and access outpatient COVID-19 treatment and preventive therapies. The session will include presentations by leaders and clinicians from DOH, DHS, and additional organizations, as well as provide an opportunity for Q&A.

Use this link to register for the webinar scheduled for Tuesday, July 12 at 4:00 pm. See the flyer for more information including registration assistance.

Our legislators are now determining whether to invest in DSP wages or place funds in the Rainy Day fund. Tell lawmakers to increase #DirectCarePA funding in the #PaBudget!

If you haven’t done so already, please reach out and urge lawmakers to increase funding to support human services professionals, so individuals and families in need get the support and care they deserve. Ask your networks to do the same.

Be sure to share our video on your social media pages, too. To share the video, check out our Facebook and Twitter pages where we have the videos posted. Be sure to “like” it and share it with your followers. Don’t forget to tag @directcareworks and use the #DirectCarePA and #PABudget hashtags so we can ensure as many people as possible see it.

It’s so important for us to share the story about how this workforce crisis is affecting individuals and families in need, as well as the providers and professionals who want to serve them.

Most importantly, TAKE ACTION TODAY. Tell lawmakers to increase funding to address the workforce crisis facing Pennsylvania’s health and human services. Thank you for your continued support.